Hot Features
プレミアム
Invivyd Inc (IVVD)
NASDAQ
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. 詳細を表示
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease Control reports XEC and KP.3.1.1 (previously disclosed...
Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets near-term (1H 2025) profitability with existing...
The New England Journal of Medicine (NEJM) Letter to the Editor outlines the novel, rapid immunobridging authorization pathway for PEMGARDA and provides an updated correlate of protection curve...
CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort B during KP.3 and KP.3.1.1...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0161 | -3.86926219659 | 0.4161 | 0.4471 | 0.38 | 679235 | 0.42002563 | CS |
| 4 | -0.12 | -23.0769230769 | 0.52 | 0.59 | 0.38 | 1810519 | 0.45825009 | CS |
| 12 | -0.5212 | -56.5783760313 | 0.9212 | 1.07 | 0.38 | 1128371 | 0.55657678 | CS |
| 26 | -0.82 | -67.2131147541 | 1.22 | 1.455 | 0.38 | 743985 | 0.71138778 | CS |
| 52 | -4.08 | -91.0714285714 | 4.48 | 5.195 | 0.38 | 709017 | 1.86960851 | CS |
| 156 | -4.3 | -91.4893617021 | 4.7 | 5.195 | 0.38 | 589196 | 2.32203448 | CS |
| 260 | -4.3 | -91.4893617021 | 4.7 | 5.195 | 0.38 | 589196 | 2.32203448 | CS |
Monksdream
5月前
Monksdream
5月前
Monksdream
5月前
Monksdream
6月前
Monksdream
6月前
Monksdream
6月前
Monksdream
7月前
TrendTrade2016
7月前
Rockstar55
7月前
TrendTrade2016
7月前
Monksdream
9月前
Invest-in-America
10月前
tw0122
10月前
Invest-in-America
1年前
MiamiGent
1年前
Invest-in-America
1年前
MiamiGent
1年前
Monksdream
1年前
makinezmoney
2年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
